The Mark H. Zangmeister Ctr is a clinical research site located in Columbus, Ohio, United States 43219.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
The Mark H. Zangmeister Ctr has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Neoplasm Metastasis, Breast Cancer, Small-Cell Lung Cancer.
Sponsors: Genentech, Inc., Hoffmann-La Roche.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Mark H. Zangmeister Ctr has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Mark H. Zangmeister Ctr has 3 clinical trials on record, with 2 currently active. Their work covers Neoplasm Metastasis, Breast Cancer, Small-Cell Lung Cancer.
The Mark H. Zangmeister Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.